Cheng X - Search Results

1

Lipid Nanoparticles Composed of Quaternary Amine-Tertiary Amine Cationic Lipid Combination (QTsome) for Therapeutic Delivery of AntimiR-21 for Lung Cancer.

Yung BC, Li J, Zhang M, Cheng X, Li H, Yung EM, Kang C, Cosby LE, Liu Y, Teng L, Lee RJ. Yung BC, et al. Among authors: cheng x. Mol Pharm. 2016 Feb 1;13(2):653-62. doi: 10.1021/acs.molpharmaceut.5b00878. Epub 2016 Jan 19. Mol Pharm. 2016. PMID: 26741162

2

The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery.

Cheng X, Lee RJ. Cheng X, et al. Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):129-137. doi: 10.1016/j.addr.2016.01.022. Epub 2016 Feb 18. Adv Drug Deliv Rev. 2016. PMID: 26900977 Review.

3

Lipid-Albumin Nanoparticles (LAN) for Therapeutic Delivery of Antisense Oligonucleotide against HIF-1α.

Li H, Quan J, Zhang M, Yung BC, Cheng X, Liu Y, Lee YB, Ahn CH, Kim DJ, Lee RJ. Li H, et al. Among authors: cheng x. Mol Pharm. 2016 Jul 5;13(7):2555-62. doi: 10.1021/acs.molpharmaceut.6b00363. Epub 2016 Jun 16. Mol Pharm. 2016. PMID: 27253378

4

Lipid Nanoparticles Loaded with an Antisense Oligonucleotide Gapmer Against Bcl-2 for Treatment of Lung Cancer.

Cheng X, Liu Q, Li H, Kang C, Liu Y, Guo T, Shang K, Yan C, Cheng G, Lee RJ. Cheng X, et al. Among authors: cheng g. Pharm Res. 2017 Feb;34(2):310-320. doi: 10.1007/s11095-016-2063-5. Epub 2016 Nov 28. Pharm Res. 2017. PMID: 27896589

5

Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis.

Zhao J, Zhao M, Yu C, Zhang X, Liu J, Cheng X, Lee RJ, Sun F, Teng L, Li Y. Zhao J, et al. Among authors: cheng x. Int J Nanomedicine. 2017 Sep 11;12:6735-6746. doi: 10.2147/IJN.S140992. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28932117 Free PMC article.

6

Folate receptor-targeted lipid-albumin nanoparticles (F-LAN) for therapeutic delivery of an Akt1 antisense oligonucleotide.

Li H, Liu Y, Chen L, Liu Q, Qi S, Cheng X, Lee YB, Ahn CH, Kim DJ, Lee RJ. Li H, et al. Among authors: cheng x. J Drug Target. 2018 Jun-Jul;26(5-6):466-473. doi: 10.1080/1061186X.2018.1433678. Epub 2018 Feb 8. J Drug Target. 2018. PMID: 29376449

7

T7 Peptide-Conjugated Lipid Nanoparticles for Dual Modulation of Bcl-2 and Akt-1 in Lung and Cervical Carcinomas.

Cheng X, Yu D, Cheng G, Yung BC, Liu Y, Li H, Kang C, Fang X, Tian S, Zhou X, Liu Q, Lee RJ. Cheng X, et al. Among authors: cheng g. Mol Pharm. 2018 Oct 1;15(10):4722-4732. doi: 10.1021/acs.molpharmaceut.8b00696. Epub 2018 Sep 7. Mol Pharm. 2018. PMID: 30138565

8

Perinatal inflammation alters histone 3 and histone 4 methylation patterns: Effects of MiR-29b supplementation.

Sugar SS, Heyob KM, Cheng X, Lee RJ, Rogers LK. Sugar SS, et al. Among authors: cheng x. Redox Biol. 2021 Jan;38:101783. doi: 10.1016/j.redox.2020.101783. Epub 2020 Nov 7. Redox Biol. 2021. PMID: 33202301 Free PMC article.

9

Dual-Ligand-Functionalized Liposomes Based on Glycyrrhetinic Acid and cRGD for Hepatocellular Carcinoma Targeting and Therapy.

Qiu M, Wang J, Bai J, Li X, Tian C, Liu Z, Zheng C, Clark AR, Cheng X, Liao X, Wu S, Lee RJ, Zhou X. Qiu M, et al. Among authors: cheng x. Mol Pharm. 2023 Apr 3;20(4):1951-1963. doi: 10.1021/acs.molpharmaceut.2c00842. Epub 2023 Mar 23. Mol Pharm. 2023. PMID: 36952242

10

Transcranial resection of falcine meningiomas by complete endoscopy with the assistance of intraoperative ultrasound.

Xiao J, Zhao T, Cheng X, Sheng Q, Li C, Li Y, Zhang Y, Wang X, Cheng H, Ye L. Xiao J, et al. Among authors: cheng x. Neurosurg Rev. 2025 Jan 4;48(1):21. doi: 10.1007/s10143-025-03186-w. Neurosurg Rev. 2025. PMID: 39753945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,057 results

Search Page

Filters